You Have a Great Story
WE KNOW HOW TO TELL IT
Bioscribe was founded in 1997 in the San Francisco Bay Area to support the area's growing biotechnology industry. For nearly 20 years, we have been a leading boutique PR agency working with companies that powered the Human Genome Project and cutting-edge start-ups that are innovating to unlock its value. We've helped launch first, second and third generation DNA sequencing systems, gene expression tools, bioinformatics software, single cell analysis solutions, molecular diagnostics, DNA forensics systems, next-generation therapies, and vaccines.
Our senior PR consultants and writers bring decades of experience and expertise in the biotech, molecular diagnostics, pharma, and life science research markets. In addition to previous large PR agency experience, some of our team members have built and run in-house communications teams, and have covered the industry as journalists and editors of leading publications.
If you need help telling your great stories, we'd love to talk to you. Contact us at
info [@] bioscribe.com.
AREAS OF EXPERTISE
We help our clients define their messaging and positioning, identify publicity opportunities, manage day-to-day corporate and product news flow, and get media coverage.
Areas of expertise include:
To submit RFPs, or to learn more about what we do, please contact us at info [@] bioscribe.com.
Media Strategy & Relations
Positioning & Messaging, Media Audits, Media Lists, Editorial Calendars, Journalist Outreach, Interview Preparation & Facilitation, Media Training, Coverage Monitoring
Editorial Strategy & Content Marketing
Editorial Planning, Customer Profiles, Content Development & Editing, Bylined Articles, White Papers, Case Studies, Marketing Collateral, Social Media & Website Content
Messaging & Positioning, Publicity Plans, Press Releases, News Distribution, Media Events, Product Placement, Tradeshow Support
Blog & Newsletter Content
Editorial Calendar Planning, Content Development, Managing Approval Process
Thought Leadership & Industry Recognition
Presentation/Talk Development, Op-Eds, Speaking Opportunities, Awards Programs
Corporate Positioning & Branding, Financing Milestones, Mergers & Expansions, Organizational Communicatons, Issues Management
It's The Companies We Keep
Our clients are innovative start-ups powering genomics, newly public companies expanding markets, industry associations supporting policy and innovation, incubators of healthcare innovation, and government agencies developing standards.
Developing therapeutic antibodies for inflammatory and proliferative diseases
San Carlos, CA
Allakos is a clinical-stage company developing antibodies that target receptor molecules present on the surface of immune effector cells involved in allergy, inflammation and tissue damage.
Actionable strategies for life sciences
Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.
Cancer diagnostics company with unique liquid biopsy technology for better monitoring of disease progression
Westlake Village, CA
Cynvenio is a commercial-stage clinical diagnostics company that leverages its proprietary LiquidBiopsy® multi-template technology for the molecular characterization of tumor cells from a standard blood draw.
Discovery and development of mitocondrial therapeutics
Gencia is focused on the discovery and development of first-in-class therapeutics for important medical needs, based on proprietary mitochondrial targeting technology and novel insights into the role of mitochondria in human health, aging, and disease.
Securely store, process, explore and share large, complex genomic datasets
Mountain View, CA
Google Genomics helps the life science community organize the world’s genomic information and make it accessible and useful. Through extensions to Google Cloud Platform, you can apply the same technologies that power Google Search and Maps to securely store, process, explore, and share large, complex datasets.
Advancing ion channel and transporter drug discovery
Icagen partners with pharmaceutical and biotechnology companies to offer industry‐leading scientific expertise and comprehensive access to technologies for ion channel and transporter drugdiscovery and development.
Integrating the digital universe of information to better diagnose and treat human disease
New York, NY
The Icahn Institute for Genomics and Multiscale Biology at Mount Sinai harnesses "Big Data" analytics to build predictive models that offer novel insights on disease, and they apply these models in a clinical setting to improve diagnosis and treatment for patients.
Evolving better science.
Wilmington, Massachusetts & Cape Town, South Africa
Kapa Biosystems is a life science reagents supplier that employs proprietary, directed-evolution technologies to optimize enzymes for next-generation sequencing applications as well as PCR and real-time PCR. Kapa Biosystems offers a portfolio of best-in-class products containing novel enzymes that confer significant performance advantages when compared to traditional wild-type enzymes.
The future of science is sound
Labcyte is revolutionizing liquid handling. Its Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions.
Breakthrough solutions to improve health and advance science
Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.
Harnessing the microbiome to improve health
Mountain View, CA
Osel, Inc. is pioneering a new class of medicine called Live Biotherapeutic Products (LBPs) that modulate the body’s natural microbiome to restore health and prevent infection. In 2003, Osel was one of the first companies to receive FDA authorization to test a live bacterial therapeutic, and is a pioneer in the field of LBPs. Women's health is their unique focus.
Investment bankers for middle market growth companies in life sciences
Wellesley, Mass and Reston, VA
Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.
Third-generation DNA sequencing for complex genomics projects
Menlo Park, CA
Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.
The global leader in applications to quickly analyze and interpret genomic data
Redwood City, CA
Ingenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems.
DNA size selection for next-gen sequencing
Sage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows.
Molecular biology lab in the Cloud
Menlo Park, CA
Transcriptic is pioneering a drug discovery revolution and setting new standards for conducting basic biological research. By offering a virtual infrastructure that includes a cloud-based robotic laboratory, researchers can spend more time guiding their scientific experiments and discoveries and less time and resources on monotonous but necessary experiments.
Replicating physiologically relevant conditions for cell-based assays
San Francisco, CA
Xcell is developing revolutionary products and workflows for life science and translational research that reproduce physiologically relevant conditions to enable more meaningful, biologically relevant experiments. The company’s tools empower scientists to obtain accurate and actionable results in important fields such as cancer research, biomarker discovery, lead candidate selection and optimization, stem cell research and regenerative medicine, and immunotherapy drug development.
Some of our past clients include:
Association for Molecular Pathology, Applied Biosystems, BD Biosciences, Benchling, Biotique Systems, Cellular Resarch (purchased by BD) Chiron Corporation, Connetics Corporation, DNAnexus, DoubleTwist, Eos, GE healthymagination, Gen9, Genentech, GenoSpectra, IntegenX, Invitrogen, Microsoft Health Solutions, Medtronic, Mohr Davidow Ventures, NanoString Technologies, Nektar, NIST: Multiplexed Biomolecular Science Group, Omicia, PAG, PaxVax, Personalis, RainDance Technologies, StationX, Varian Medical Systems, VitaPath Genetics, Zyomyx
President & CEO
Nicole founded Bioscribe in 1997 in San Francisco to meet the communications needs of the emerging biotech industry. She has more than 20 years experience providing PR counsel to Fortune 500 companies, small start-ups, and non-profit associations in this industry.
Vice President, Editorial Strategy
OUR CLIENTS IN THE NEWS
Here is a sample of some of the stories we are helping to tell...
We are a small group of senior, self-directed professionals passionate about helping clients communicate stories about life science innovations. We are currently recruiting PR counselors, media relations pros, and scientific marketing content writers and MarCom experts who have experience working on biotech accounts. Please send a copy of your resume to us (info [at] bioscribe [dot] com). If it looks like a great match, we'll be in touch. Thanks!